Skip to main content

MoneyWorks4Me

Morepen Laboratories informs about press release

09 Nov 2026 Evaluate
Morepen Laboratories has informed that it enclosed press release with the title ‘Morepen enters U.S. prescription generics market, building on its established API strengths’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1908.45
Dr. Reddys Labs. 1385.20
Cipla 1421.45
Lupin 1996.00
Zydus Lifesciences 1199.90
View more..